Consensus IDEXX Laboratories, Inc. Borsa Italiana

Stocks

1IDXX

US45168D1046

Medical Equipment, Supplies & Distribution

Real-time Estimate Tradegate 03:50:45 03/10/26 am AEST			5-day change	1st Jan Change
463.15 ^EUR	-0.57%		+2.31%	-19.86%

01/10	IDEXX Laboratories Acquires Veterinary AI Platform CoVetAI	MT
17/09	Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Amid Economic Data, Fed Rate Hike	MT

c962e78816b1e7e21c5.8ms40FLiasiQ1AdnuBDWNyIHQpz9W9Ic3YSlQoEJG98.oxxJgyKHXrrxi0oo_EiGDmUzdqikNoBdjd7BA7Rob7S0OA6HJ6pag6CDVg~e9022157fe0b90f02545f4a7f550f63e

Analysts' recommendations: IDEXX Laboratories, Inc.

11/08	Barclays Adjusts Price Target on IDEXX Laboratories to $710 From $800, Keeps Overweight Rating	MT
06/08	Jefferies Adjusts Price Target on IDEXX Laboratories to $795 From $792	MT
06/08	Citigroup Adjusts Price Target on IDEXX Laboratories to $670 From $650	MT
05/08	UBS Adjusts Price Target on IDEXX Laboratories to $670 From $620, Maintains Neutral Rating	MT
28/07	Elanco Seems Best-Positioned Into Q2 Print Among Animal Health Stocks, UBS Says	MT
28/07	UBS Cuts IDEXX Laboratories Price Target to $620 From $640, Maintains Neutral Rating	MT
13/07	Leerink Partners Adjusts IDEXX Laboratories Price Target to $715 From $725, Maintains Outperform Rating	MT
06/05	Rothschild & Co Redburn Adjusts Price Target on IDEXX Laboratories to $665 From $655	MT
06/05	Jefferies Adjusts Price Target on IDEXX Laboratories to $792 From $785	MT
28/04	UBS Adjusts Price Target on IDEXX Laboratories to $640 From $730, Maintains Neutral Rating	MT
27/04	Jefferies Adjusts Price Target on IDEXX Laboratories to $785 From $820, Maintains Buy Rating	MT
15/04	Citigroup Initiates IDEXX Laboratories at Neutral With $650 Price Target	MT
14/04	Leerink Partners Adjusts IDEXX Laboratories PT to $725 From $760, Maintains Outperform Rating	MT
31/03	Stifel Nicolaus Adjusts IDEXX Laboratories PT to $675 From $775, Maintains Buy Rating	MT
09/02	Piper Sandler Adjusts Price Target on IDEXX Laboratories to $750 From $775, Maintains Neutral Rating	MT
06/02	Barclays Adjusts Price Target on IDEXX Laboratories to $800 From $850, Maintains Overweight Rating	MT
05/02	Barclays Lowers Price Target on IDEXX Laboratories to $800 From $850	MT
04/02	Jefferies Adjusts Price Target on IDEXX Laboratories to $820 From $830	MT
04/02	UBS Adjusts IDEXX Laboratories PT to $730 From $750	MT
03/02	Leerink Partners Adjusts Price Target on IDEXX Laboratories to $760 From $785	MT
03/02	BTIG Adjusts Price Target on IDEXX Laboratories to $800 From $830	MT
03/02	Rothschild & Co Redburn Adjusts Price Target on IDEXX Laboratories to $655 From $700	MT
10/12	Barclays Initiates IDEXX Laboratories With Overweight Rating, $850 Price Target	MT
11/11	Piper Sandler Adjusts Price Target on IDEXX Laboratories to $775 From $700	MT
05/11	UBS Adjusts Price Target on IDEXX Laboratories to $750 From $710, Maintains Neutral Rating	MT

More recommendations

Veterinary Medical Equipment & Supplies

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+24.38%
	MEDTRONIC PLC					+21.28%
	STRYKER CORPORATION					+34.74%
	ESSILORLUXOTTICA					+60.86%
	CENCORA, INC.					+19.2%
	HOYA CORPORATION					+23.82%
	BECTON, DICKINSON AND COMPANY					+9.88%
	IDEXX LABORATORIES, INC.					+35.46%
	DEXCOM, INC.					+10.26%
	Average					+26.65%
	Weighted average by Cap.					+27.90%